Literature DB >> 17492294

TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease.

Linda K Kwong1, Manuela Neumann, Deepak M Sampathu, Virginia M-Y Lee, John Q Trojanowski.   

Abstract

The rapid confirmation of the initial report by Neumann et al. (Science 314:130-133, 2006) that transactive response (TAR)-DNA-binding protein 43 (TDP-43) is the major disease protein linking frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) with and without motor neuron disease (MND) as well as amyotrophic lateral sclerosis (ALS) implies that TDP-43 proteinopathy underlies major forms of sporadic as well as familial FTLD and ALS. Not only was the identity of the ubiquitinated proteins that accumulate in neurons and glia of these disorders finally resolved, but it also was shown that pathologic TDP-43 was hyperphosphorylated, ubiquitinated and cleaved to generate C-terminal fragments in affected brain and spinal cord of FTLD-U and ALS. This review summarizes the growing evidence that TDP-43 proteinopathy is the common pathologic substrate linking FTLD and ALS, and it considers the implications of these findings for developing better strategies to diagnose and treat these neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17492294     DOI: 10.1007/s00401-007-0226-5

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  96 in total

Review 1.  TAR DNA-binding protein 43 in neurodegenerative disease.

Authors:  Alice S Chen-Plotkin; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurol       Date:  2010-03-16       Impact factor: 42.937

2.  Design, Synthesis, and Properties of Phosphoramidate 2',5'-Linked Branched RNA: Toward the Rational Design of Inhibitors of the RNA Lariat Debranching Enzyme.

Authors:  Nobuhiro Tago; Adam Katolik; Nathaniel E Clark; Eric J Montemayor; Kohji Seio; Mitsuo Sekine; P John Hart; Masad J Damha
Journal:  J Org Chem       Date:  2015-09-30       Impact factor: 4.354

3.  Frontal cortex neuropathology in dementia pugilistica.

Authors:  Tommy Saing; Malcolm Dick; Peter T Nelson; Ronald C Kim; David H Cribbs; Elizabeth Head
Journal:  J Neurotrauma       Date:  2012-04-10       Impact factor: 5.269

4.  Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability.

Authors:  Antonella Caccamo; Smita Majumder; Janice J Deng; Yidong Bai; Fiona B Thornton; Salvatore Oddo
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

Review 5.  Update on recent molecular and genetic advances in frontotemporal lobar degeneration.

Authors:  Eileen H Bigio
Journal:  J Neuropathol Exp Neurol       Date:  2008-07       Impact factor: 3.685

6.  TAR DNA-binding protein-43 in amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and Alzheimer disease.

Authors:  Eileen H Bigio
Journal:  Acta Neuropathol       Date:  2008-06-25       Impact factor: 17.088

7.  TDP-43 variants of frontotemporal lobar degeneration.

Authors:  Eileen H Bigio
Journal:  J Mol Neurosci       Date:  2011-05-24       Impact factor: 3.444

Review 8.  TDP-43/FUS in motor neuron disease: Complexity and challenges.

Authors:  Erika N Guerrero; Haibo Wang; Joy Mitra; Pavana M Hegde; Sara E Stowell; Nicole F Liachko; Brian C Kraemer; Ralph M Garruto; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2016-09-28       Impact factor: 11.685

9.  Transgenic rat model of neurodegeneration caused by mutation in the TDP gene.

Authors:  Hongxia Zhou; Cao Huang; Han Chen; Dian Wang; Carlisle P Landel; Pedro Yuxing Xia; Robert Bowser; Yong-Jian Liu; Xu Gang Xia
Journal:  PLoS Genet       Date:  2010-03-26       Impact factor: 5.917

Review 10.  Molecular neuropathology of TDP-43 proteinopathies.

Authors:  Manuela Neumann
Journal:  Int J Mol Sci       Date:  2009-01-09       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.